[Refractory effect and alloimmunization after transfusion of thrombocytes]

Area of Science:

• Hematology
• Immunology
• Transfusion Medicine

Background:

• Alloimmunization to human leukocyte antigens (HLA) is a significant complication in patients with acute leukemia receiving platelet transfusions.
• Refractoriness to platelet transfusions can lead to treatment challenges and poorer outcomes.

Purpose of the Study:

• To explore strategies for preventing or delaying HLA-alloimmunization in acute leukemia patients undergoing platelet therapy.
• To evaluate the impact of different platelet transfusion products and processing methods on alloimmunization incidence.

Main Methods:

• Review of current practices and proposed methods for HLA-alloimmunization prevention.
• Consideration of single random donor platelets versus pooled random donor platelets.
• Analysis of the effects of leukocyte reduction and ultraviolet irradiation of platelet concentrates.

Main Results:

• Using single random donor platelets may prevent or delay HLA-alloimmunization compared to pooled platelets.
• Leukocyte removal and ultraviolet irradiation of platelet concentrates are examined for their potential role in reducing alloimmunization.

Conclusions:

• Single donor platelet transfusions represent a viable strategy to mitigate HLA-alloimmunization risk in acute leukemia.
• Further investigation into processing techniques like leukocyte removal and irradiation is warranted to optimize prevention strategies.